BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10373483)

  • 1. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression.
    Kwon G; Xu G; Marshall CA; McDaniel ML
    J Biol Chem; 1999 Jun; 274(26):18702-8. PubMed ID: 10373483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.
    Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA
    Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts.
    Simonin MA; Bordji K; Boyault S; Bianchi A; Gouze E; Bécuwe P; Dauça M; Netter P; Terlain B
    Am J Physiol Cell Physiol; 2002 Jan; 282(1):C125-33. PubMed ID: 11742805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
    FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW; Chang YH; Tsi CJ; Lin WW
    J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells.
    Ikeda U; Shimpo M; Murakami Y; Shimada K
    Hypertension; 2000 Jun; 35(6):1232-6. PubMed ID: 10856269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
    Bernardo A; Levi G; Minghetti L
    Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes.
    Mendez M; LaPointe MC
    Hypertension; 2003 Oct; 42(4):844-50. PubMed ID: 12885795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1 produced and released endogenously within human islets inhibits beta cell function.
    Arnush M; Heitmeier MR; Scarim AL; Marino MH; Manning PT; Corbett JA
    J Clin Invest; 1998 Aug; 102(3):516-26. PubMed ID: 9691088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
    Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
    Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes.
    Kasai K; Banba N; Hishinuma A; Matsumura M; Kakishita H; Matsumura M; Motohashi S; Sato N; Hattori Y
    Am J Physiol Cell Physiol; 2000 Dec; 279(6):C1859-69. PubMed ID: 11078701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells.
    Hattori Y; Hattori S; Kasai K
    Hypertension; 1999 Apr; 33(4):943-8. PubMed ID: 10205228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
    Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo.
    Heneka MT; Klockgether T; Feinstein DL
    J Neurosci; 2000 Sep; 20(18):6862-7. PubMed ID: 10995830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells.
    Weber SM; Scarim AL; Corbett JA
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E329-36. PubMed ID: 14600076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli.
    Guyton K; Zingarelli B; Ashton S; Teti G; Tempel G; Reilly C; Gilkeson G; Halushka P; Cook J
    Shock; 2003 Jul; 20(1):56-62. PubMed ID: 12813370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-stranded RNA inhibits beta-cell function and induces islet damage by stimulating beta-cell production of nitric oxide.
    Heitmeier MR; Scarim AL; Corbett JA
    J Biol Chem; 1999 Apr; 274(18):12531-6. PubMed ID: 10212230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells.
    Takeda K; Ichiki T; Tokunou T; Iino N; Takeshita A
    J Biol Chem; 2001 Dec; 276(52):48950-5. PubMed ID: 11687581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.